DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cardura XL (Doxazosin Mesylate) - Indications and Dosage

 
 



INDICATIONS AND USAGE

CARDURA XL is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).

CARDURA XL is not indicated for the treatment of hypertension.

DOSAGE AND ADMINISTRATION

The initial dose of CARDURA XL, 4 mg given once daily, should be administered with breakfast. Depending on the patient's symptomatic response and tolerability, the dose may be increased to 8 mg, the maximum recommended dose. The recommended titration interval is 3–4 weeks. If CARDURA XL administration is discontinued for several days, therapy should be restarted using the 4 mg once daily dose. Tablets should be swallowed whole, and must not be chewed, divided, cut or crushed.

If switching from CARDURA to CARDURA XL, therapy should be initiated with the lowest dose (4mg once daily). Prior to starting therapy with CARDURA XL, the final evening dose of CARDURA should not be taken.

HOW SUPPLIED

CARDURA XL (doxazosin mesylate extended release tablets) are available as 4 mg (white, imprinted with CXL 4) and 8 mg (white, imprinted with CXL 8) tablets.

Bottles of 30:          4 mg (NDC 0049-2710-30)

                              8 mg (NDC 0049-2720-30)

Manufactured by: Pfizer Inc, New York, NY 10017

Recommended Storage: Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F) [See USP Controlled Room Temperature]

Rx only

Month/Year

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014